Search for: "Santarus, Inc." Results 1 - 17 of 17
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Sep 2012, 9:59 pm by Patent Docs
District Court for the District of Delaware's decision in Santarus, Inc. v. [read post]
5 Sep 2012, 5:51 pm by Mandour & Associates
IPNews® - The Federal Circuit on Tuesday partially reversed a lower court's finding that a number of Santarus Inc.'s patent claims for its heartburn drug Zegerid are invalid, giving Santarus another crack at hanging Par Pharmaceuticals Inc. out to dry for trying to market a generic version of the drug. [read post]
5 Sep 2012, 5:45 pm
California - The Federal Circuit on Tuesday gave Santarus Inc. another chance to prove that its patents for the heartburn drug Zegerid are valid and that Par Pharmaceuticals Inc.'s proposed generic version would infringe those patents. [read post]
10 Feb 2012, 7:32 am by Mark Zamora
 Clostridium difficile is a bacterium that can cause colitis and other intestinal conditions.The FDA said patients who develop diarrhea after taking these drugs should be checked for CDAD.The drugs called proton pump inhibitors (PPIs) are widely used for treating ulcers, acid reflux and other conditions.Other PPIs sold by prescription include Takeda Pharmaceutical Co Ltd's Dexilant and Prevacid, AstraZeneca's Prilosec and Vimovo, Santarus Inc's Zegerid, and… [read post]
15 Jun 2015, 3:57 am by Derek T. Braslow
Among the PPIs identified in the study as linked to an increased risk of heart attack, the following are common in prescription or over- the-counter form: • Prilosec – manufactured by AstraZeneca • Prilosec OTC – manufactured by Procter & Gamble • Nexium – manufactured by AstraZeneca and now available over the counter • Zegerid OTC – manufactured by Merck & Col and Santarus, Inc. [read post]
14 Jan 2013, 7:01 am by Gene Quinn
” A Federal Circuit decision dealing with that limitation (Santarus, Inc. v. [read post]